Layered drug nanoparticles can now be produced efficiently and at scale using a microfluidic method that eliminates purification and improves consistency. Since its adaptation to nanoscale materials, ...

AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into ...

Microfluidic mixing techniques and devices are pivotal in advancing applications ranging from chemical synthesis to biomedical diagnostics. In these systems, liquids or gases are combined in channels ...

Genizer's NanoMixer is a microfluidic mixer designed for laboratory use. This nanomixer prepares mRNA, DNA, siRNA delivery systems, and various other nanoparticles. It is an electronic device that ...

It has taken little more than a decade for microfluidics-based systems to become accepted and integrated into drug discovery by Big Pharma companies such as Merck, J&J, Pfizer, Lilly, Tashio, Amgen, ...

Lipopolyplexes are emerging as effective, second-generation, nonviral vectors to deliver gene therapies, yet there are challenges. To resolve them, researchers at the University of Milan have ...

The primary components of LNP–RNA are ionizable lipids, cholesterol, PEGylated lipids, and phospholipids, which together form the nanoparticle, along with the active pharmaceutical ingredient, RNA.